Contineum Therapeutics, Inc.
CTNM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855175
In the last 90 days, Contineum Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $500.6M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q1 2026 vs. Q4 2025
How the institutions holding Contineum Therapeutics, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 80 | 1 | 90 | +11 |
| Shares | 29.6M | 1.27M | 30.6M | +2.22M (+7.8%) |
| Value | $338.3M | $14.5M | $398.9M | +$75.2M (+23.2%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Contineum Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 1,214,173 | $15.9M | 0.00% |
| Jones Hill Capital LP | 513,053 | $6.70M | 1.44% |
| Citadel Advisors LLC | 350,200 | $4.57M | 0.00% |
| Vanguard Fiduciary Trust Co | 153,924 | $2.01M | 0.00% |
| Ishara Investments LP | 142,000 | $1.85M | 1.87% |
| Verdad Advisers, LP | 86,032 | $1.12M | 1.26% |
| Dimensional Fund Advisors LP | 59,946 | $782.1K | 0.00% |
| Squarepoint Ops LLC | 59,844 | $781.6K | 0.00% |
| Wellington Management Group LLP | 55,609 | $726.3K | 0.00% |
| XTX Topco Ltd | 35,846 | $468.1K | 0.01% |
| Seven Fleet Capital Management LP | 27,054 | $353.3K | 0.11% |
| Jain Global LLC | 22,984 | $300.2K | 0.00% |
| HRT Financial LP | 22,170 | $289.0K | 0.00% |
| Canada Pension Plan Investment Board | 20,600 | $269.0K | 0.00% |
| Quarry LP | 16,000 | $209.0K | 0.04% |
| Engineers Gate Manager LP | 14,956 | $195.3K | 0.00% |
| Cannon Global Investment Management, LLC | 13,000 | $169.8K | 0.41% |
| Diametric Capital, LP | 10,729 | $140.1K | 0.04% |
| Vanguard Global Advisers, LLC | 10,265 | $134.1K | 0.00% |
| US Bancorp | 123 | $1.61K | 0.00% |
| Advisor Group Holdings, Inc. | 6 | $78 | 0.00% |
| Caitong International Asset Management Co., Ltd | 1 | $13 | 0.00% |
Sold out (11)
Institutions that held Contineum Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Commodore Capital LP | 816,326 | $9.33M |
| Ameriprise Financial Inc | 209,633 | $2.40M |
| Monashee Investment Management LLC | 137,430 | $1.57M |
| Samsara BioCapital, LLC | 72,245 | $825.8K |
| Schonfeld Strategic Advisors LLC | 22,673 | $259.1K |
| Graham Capital Management, L.P. | 17,074 | $195.2K |
| Occudo Quantitative Strategies LP | 15,036 | $171.9K |
| Persistent Asset Partners Ltd | 13,853 | $158.3K |
| Fortitude Family Office, LLC | 445 | $5.09K |
| Optiver Holding B.V. | 104 | $1.19K |
| Group One Trading, L.P. | 103 | $1.18K |
Not filed for Q1 2026 yet (1)
Institutions that held Contineum Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 1,270,858 | $14.5M |